Finally, Light at the End of the Pandemic

Medical technicians work at a drive-through coronavirus testing facility at Regeneron Pharmaceuticals’s Westchester campus in Tarrytown, N.Y., September 17, 2020. (Brendan McDermid/Reuters)
Rapid improvements in prevention and treatment could end the pandemic sooner than people think.

NRPLUS MEMBER ARTICLE W hen the announcement came on October 2 that President Trump had tested positive for COVID-19, his supporters — and more than a few critics — prayed for his speedy recovery. At the age of 74 and with at least one significant comorbidity, Trump was at high risk of a severe and potentially fatal bout of COVID-19.

Little did he or anyone else know, his timing could not have been better. Just three days earlier, a company called Regeneron Pharmaceuticals announced that clinical trials of its futuristic new treatment had succeeded in reducing both infection and the time it takes for alleviation

To Read the Full Story
Mario Loyola is a senior fellow at the Competitive Enterprise Institute, the director of the Environmental Finance and Risk Management Program of Florida International University, and a visiting fellow at the National Security Institute of George Mason University. The opinions expressed in this column are his alone.

Recommended

The Latest